Form: 3

Initial statement of beneficial ownership of securities

March 4, 2021

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Sawicki Mark W
(Last) (First) (Middle)
C/O CRYOPORT, INC.
112 WESTWOOD PLACE, SUITE 350
(Street)
BRENTWOOD TN 37027
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/25/2021 		3. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [ CYRX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Scientific Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 19,000 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option to purchase common stock (1) 08/20/2025 Common Stock 11,342 3.07 D
Option to purchase common stock (2) 05/06/2026 Common Stock 7,231 1.87 D
Option to purchase common stock (3) 03/28/2028 Common Stock 68,000 8.65 D
Option to purchase common stock (4) 04/01/2029 Common Stock 90,000 12.79 D
Option to purchase common stock (5) 03/30/2030 Common Stock 100,000 16.93 D
Option to purchase common stock (6) 05/18/2027 Common Stock 11,831 3.21 D
Option to purchase common stock (7) 05/07/2025 Common Stock 77,625 7.8 D
Explanation of Responses:
1. 1/48th of the 156,400 options originally granted vested on the 19th of each month for forty-eight months beginning September 19, 2015.
2. 1/48th of the 70,000 options originally granted vested on the 6th of each month for forty-eight months beginning June 6, 2016.
3. 1/48th of the 68,000 options originally granted vested on the 28th of each month for forty-eight months beginning April 28, 2018.
4. 1/48th of the 90,000 options originally granted vested on the 1st of each month for forty-eight months beginning May 1, 2019.
5. 1/48th of the 100,000 options originally granted vested on the 30th of each month for forty-eight months beginning April 30, 2020.
6. 1/48th of the 78,000 options originally granted vested on the 18th of each month for forty-eight months beginning June 18, 2017.
7. 1/48th of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015.
/s/ Mark W. Sawicki 03/04/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.